Furthermore, lncRNA AFAP1-AS1 was found to modulate NSCLC cell proliferation via interacting with EZH2 and recruiting EZH2 to the promoter regions of p21, thus inhibiting p21 expression (12). The gene discussed is EZH2; the disease is non-small cell lung carcinoma.